Their backup plan was already executed: they switched from their testing methodology to acting as a service provider for somebody else&#x27;s testing methodology (<a href="http:&#x2F;&#x2F;www.businessinsider.com&#x2F;bill-maris-explains-why-gv-didnt-invest-in-theranos-2015-10" rel="nofollow">http:&#x2F;&#x2F;www.businessinsider.com&#x2F;bill-maris-explains-why-gv-di...</a> &quot;&quot;&quot;So, we just had someone from our life-science investment team go into Walgreens and take the test. And it wasn&#x27;t that difficult for anyone to determine that things may not be what they seem here.&quot;<p>That employee found that when he went to get a test done, Theranos wanted more than just a drop of blood in one of its &quot;nanotainers.&quot; He denied a full venous blood draw, and ended up getting called back a week later because they wanted him to give more blood.&quot;&quot;&quot;)